These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 404447)

  • 1. [Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)].
    Mita T; Mayumi K; Kataoka N; Ishigami J
    Jpn J Antibiot; 1977 Mar; 30(3):215-22. PubMed ID: 404447
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with amikacin (BB-K8) (author's transl)].
    Nakagawa K; Watanabe K; Kabe J; Suzuki T; Koyama S
    Jpn J Antibiot; 1974 Jun; 27(3):337-42. PubMed ID: 4215897
    [No Abstract]   [Full Text] [Related]  

  • 3. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Laboratory and clinical investigation of amikacin (BB-K8) (author's transl)].
    Kato Y; Saito A; Ishikawa K; Nakayama I; Tomizawa M
    Jpn J Antibiot; 1974 Jun; 27(3):343-7. PubMed ID: 4215898
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with amikacin for chronic complicated urinary tract infections in myelopathogenic bladder. Clinical effect against gentamicin-resistant bacteria (author's transl)].
    Konya H; Kuroda J; Iwao N; Morita M
    Jpn J Antibiot; 1978 Jul; 31(7):341-5. PubMed ID: 691255
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fundamental and clinical studies on BB-K8 (amikacin), a new semisynthetic aminoglycoside antibiotic (author's transl)].
    Ueda Y; Uba F; Go K; Okamoto Y; Okubo H
    Jpn J Antibiot; 1974 Jun; 27(3):354-65. PubMed ID: 4215900
    [No Abstract]   [Full Text] [Related]  

  • 7. [Single daily dose of amikacin in the treatment of urinary tract infections].
    de Azevedo TH; de Oliveira MM; Rocha H
    AMB Rev Assoc Med Bras; 1980 Apr; 26(4):140-2. PubMed ID: 6968958
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hospital-acquired urinary infections with amikacin (author's transl)].
    Weidner W; Nöske HD; Sziegoleit A; Schröder R; Leidenfrost U
    Med Klin; 1979 Jul; 74(27):1071-6. PubMed ID: 470792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on a new aminoglycoside antibiotic, amikacin (BB-K8) in pediatrics (author's transl)].
    Nakazawa S; Sato H; Watanabe O; Fujii N; Oka S
    Jpn J Antibiot; 1974 Aug; 27(4):438-45. PubMed ID: 4215904
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of dermatological cases with BB-K8 (author's transl)].
    Kameyama A; Maruta H; Minami K
    Jpn J Antibiot; 1975 Aug; 28(4):525-9. PubMed ID: 808656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory and clinical studies on amikacin (BB-K8), a new semisynthetic aminoglycoside (author's transl)].
    Isogai K; Shimizu Y; Kawada Y; Nishiura T
    Jpn J Antibiot; 1974 Jun; 27(3):328-36. PubMed ID: 4140246
    [No Abstract]   [Full Text] [Related]  

  • 12. Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
    Craven PC; Jorgensen JH; Kaspar RL; Drutz DJ
    Am J Med; 1977 Jun; 62(6):902-10. PubMed ID: 326046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amikacin therapy for serious infections in hematopoietic disorders (author's transl)].
    Fujii H; Shimizu T
    Jpn J Antibiot; 1981 Jun; 34(6):841-51. PubMed ID: 7289039
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
    Maslow MJ; Simberkoff MS; Rahal JJ
    J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on amikacin (BB-K8) (author's transl)].
    Seiga K; Minagawa M; Furuta N; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1974 Aug; 27(4):434-7. PubMed ID: 4215903
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with intravenous drip infusion of amikacin in urological field (author's transl)].
    Murahashi I; Toyoda A; Takasaki E
    Jpn J Antibiot; 1981 Feb; 34(2):133-9. PubMed ID: 7253190
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of absorption and excretion of powdery preparation for injection and liquid preparation of BB-K8 (amikacin) (author's transl)].
    Okubo H; Okamoto Y; Uba F; Ueda Y; Ueda T
    Jpn J Antibiot; 1975 Jun; 28(3):283-7. PubMed ID: 1152282
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Pseudomonas aeruginosa pneumonia with amikacin (author's transl)].
    Izawa T; Katakura K
    Jpn J Antibiot; 1979 Apr; 32(4):532-4. PubMed ID: 110964
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic effect of amikacin for infections with gram-negative bacilli, especially for stubborn respiratory infections (author's transl)].
    Oizumi K; Watanabe A; Konno K; Hayashi I; Kawamorida K; Nagai K; Kudo S; Kurita K; Kaishio K
    Jpn J Antibiot; 1978 Jan; 31(1):15-23. PubMed ID: 633626
    [No Abstract]   [Full Text] [Related]  

  • 20. Patterns and mechanisms of emergence of resistance to amikacin.
    Meyer RD
    J Infect Dis; 1977 Sep; 136(3):449-52. PubMed ID: 409785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.